Capecitabine (X) and taxanes in patients (pts) with anthracycline-pretreated metastatic breast cancer (MBC): sequential vs. combined therapy results from the Mexican Oncology Study Group.

被引：0
|
作者：
Torrecillas, L [1 ]
Soto, C [1 ]
Cervantes, G [1 ]
Benitez, H [1 ]
Acosta, A [1 ]
Cortes, P [1 ]
Gonzalez, F [1 ]
Zamora, R [1 ]
Rodriguez, G [1 ]
Silva, A [1 ]
Leoner, C [1 ]
Sauza, F [1 ]
Suarez, T [1 ]
Tokunaga, J [1 ]
Erazo, A [1 ]
Talavera, J [1 ]
机构：
[1] IMSS, Mexico City, DF, Mexico
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2004年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S200 / S200
页数：1
相关论文
共 50 条
  • [1] Capecitabine (X) and taxanes in patients (pts) with anthracycline-pretreated metastatic breast cancer (MBC): Sequential vs. combined therapy results from a MOSG randomized phase III trial.
    Soto, C.
    Torrecillas, L.
    Reyes, S.
    Ramirez, M.
    Perez, L.
    Cervantes, G.
    Gonzalez, F.
    Tellez, E.
    Cortes, P.
    Benitez, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 20S - 20S
  • [2] Prognostic factors may aid treatment decisions when considering sequential or combined capecitabine (X)-based therapy for patients (pts) with anthracycline-pretreated metastatic breast cancer (MBC): Mexican Oncology Study Group.
    Perez-Michel, L
    Ramirez, M
    Delgadillo, F
    Aguilar, C
    Tellez, E
    Palomo, A
    Silva, M
    Loredo, T
    Aldaco, F
    Torrecillas, L
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S200 - S201
  • [3] Economic evaluation of sequential capecitabine (X) and taxanes vs. the combinations in patients (pts) with advanced/metastatic breast cancer (MBC): a Mexican Oncology Study Group (MOSG) trial.
    Reynoso, N
    Torrecillas, L
    Soto, C
    Reyes, S
    Perez-Michel, L
    Ramirez, M
    Cervantes, G
    Benitez, H
    Delgadillo, F
    Talavera, J
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S219 - S219
  • [4] Preliminary results of Capecitabine (C) associated with Vinorelbine (V) in taxane and anthracycline-pretreated metastatic breast cancer (MBC)
    Estevez, L. G.
    Batista, N.
    Sanchez-Rovira, P.
    Velasco, A.
    Domine, M.
    Lobo, F.
    Oramas, J.
    Cruz, J.
    ANNALS OF ONCOLOGY, 2004, 15 : 44 - 44
  • [5] Efficacy of Capecitabine (X) monotherapy in anthracycline-pretreated metastatic breast cancer (MBC): preliminary results of phase II study(Experienced in single institution)
    Kurnianda, Johan
    Haryadi, Achmad
    Aryandono, Teguh
    ANNALS OF ONCOLOGY, 2004, 15 : 41 - 41
  • [6] Gemcitabine plus docetaxel (GD) versus capecitabine plus docetaxel (CD) for anthracycline-pretreated metastatic breast cancer (MBC) patients (pts): Results of a European phase III study.
    Chan, S
    Romieu, G
    Huober, J
    Delozier, T
    Tubiana-Hulin, M
    Lluch, A
    Schneeweiss, A
    Llombart, A
    Carrasco, E
    Fumoleau, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 24S - 24S
  • [7] Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer
    Batista, N
    Perez-Manga, G
    Constenla, M
    Ruiz, A
    Carabantes, F
    Castellanos, J
    Barón, MG
    Villman, K
    Söderberg, M
    Ahlgren, J
    Casinello, J
    Regueiro, P
    Murias, A
    BRITISH JOURNAL OF CANCER, 2004, 90 (09) : 1740 - 1746
  • [8] Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer
    N Batista
    G Perez-Manga
    M Constenla
    A Ruiz
    F Carabantes
    J Castellanos
    M Gonzalez Barón
    K Villman
    M Söderberg
    J Ahlgren
    J Casinello
    P Regueiro
    A Murias
    British Journal of Cancer, 2004, 90 : 1740 - 1746
  • [9] Capecitabine (X) combined with vinorelbine (V) in Chinese patients (pts) with metastatic breast cancer (MBC).
    Xu, B
    Tian, L
    Wu, Q
    Zhou, M
    Wang, H
    Tong, Z
    Li, H
    Li, L
    Hu, G
    Shi, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 62S - 62S
  • [10] Dose-finding study of capecitabine in combination with weekly paclitaxel for patients with anthracycline-pretreated metastatic breast cancer
    Susnjar, S.
    Bosnjak, S.
    Radulovic, S.
    Stevanovic, J.
    Gajic-Dobrosavljevic, M.
    Kreacic, M.
    JOURNAL OF BUON, 2007, 12 (02): : 189 - 196
12345